UK markets closed

Transgene SA (TRGNF)

Other OTC - Other OTC Delayed price. Currency in USD
Add to watchlist
1.62000.0000 (0.00%)
At close: 01:14PM EDT
Show:
Income statement
Balance sheet
Annual

Cash flow

Currency in EUR. All numbers in thousands
Breakdown
ttm
31/12/2023
31/12/2022
31/12/2021
31/12/2020
Cash flows from operating activities
Net income
-22,328
-22,328
-32,804
-19,536
-17,231
Depreciation & amortisation
1,572
1,572
1,686
2,521
1,786
Stock-based compensation
290
290
2,675
3,002
1,744
Change in working capital
-7,065
-7,065
5,090
-6,764
-8,681
Inventory
-
-
-
-
0
Other working capital
-37,417
-37,417
-21,838
-26,595
-29,594
Other non-cash items
-7,265
-7,265
3,282
-3,846
-7,082
Net cash provided by operating activities
-34,671
-34,671
-20,303
-25,909
-28,742
Cash flows from investing activities
Investments in property, plant and equipment
-2,746
-2,746
-1,535
-686
-852
Purchases of investments
-
-
0
-40,000
-
Sales/maturities of investments
22,973
22,973
21,807
17,704
-
Other investing activities
332
-
-
-
-
Net cash used for investing activities
34,572
34,572
20,272
-5,789
17,742
Net change in cash
11,263
11,263
-1,508
634
3,934
Cash at beginning of period
4,403
4,403
5,911
5,277
1,343
Cash at end of period
15,666
15,666
4,403
5,911
5,277
Free cash flow
Operating cash flow
-34,671
-34,671
-20,303
-25,909
-28,742
Capital expenditure
-2,746
-2,746
-1,535
-686
-852
Free cash flow
-37,417
-37,417
-21,838
-26,595
-29,594